|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Wen J and Zhang W: MIIP, a
cytoskeleton regulator that blocks cell migration and invasion,
delays mitosis and suppresses tumorogenesis. Curr Protein Pept Sci.
12:68–73. 2011. View Article : Google Scholar
|
|
4
|
Bartolini F and Gundersen GG: Formins and
microtubules. Biochim Biophys Acta. 1803:164–173. 2010. View Article : Google Scholar :
|
|
5
|
Wallar BJ and Alberts AS: The formins:
Active scaffolds that remodel the cytoskeleton. Trends Cell Biol.
13:435–446. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gaillard J, Ramabhadran V, Neumanne E,
Gurel P, Blanchoin L, Vantard M and Higgs HN: Differential
interactions of the formins INF2, mDia1 and mDia2 with
microtubules. Mol Biol Cell. 22:4575–4587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li F and Higgs HN: The mouse Formin mDia1
is a potent actin nucleation factor regulated by autoinhibition.
Curr Biol. 13:1335–1340. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi Y, Zhang J, Mullin M, Dong B, Alberts
AS and Siminovitch KA: The mDial formin is required for neutrophil
polarization, migration and activation of the LARG/RhoA/ROCK
signaling axis during chemotaxis. J Immunol. 182:3837–3845. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Magdalena J, Millard TH and Machesky LM:
Microtubule involvement in NIH 3T3 Golgi and MTOC polarity
establishment. J Cell Sci. 116:743–756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fernandez-Borja M, Janssen L, Verwoerd D,
Hordijk P and Neefjes J: RhoB regulates endosome transport by
promoting actin assembly on endosomal membranes through Dia1. J
Cell Sci. 118:2661–2670. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamana N, Arakawa Y, Nishino T, Kurokawa
K, Tanji M, Itoh RE, Monypenny J, Ishizaki T, Bito H, Nozaki K, et
al: The Rho-mDia1 pathway regulates cell polarity and focal
adhesion turnover in migrating cells through mobilizing Apc and
c-Src. Mol Cell Biol. 26:6844–6858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stamenkovic I: Extracellular matrix
remodelling: The role of matrix metalloproteinases. J Pathol.
200:448–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar
|
|
14
|
Schnaeker EM, Ossig R, Ludwig T, Dreier R,
Oberleithner H, Wilhelmi M and Schneider SW: Microtubule-dependent
matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis:
Prerequisite in human melanoma cell invasion. Cancer Res.
64:8924–8931. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nature Rev.
2:161–174. 2002.
|
|
16
|
Sullu Y, Demirag GG, Yildirim A, Karagoz F
and Kandemir B: Matrix metalloproteinase-2 (MMP-2) and MMP-9
expression in invasive ductal carcinoma of the breast. Pathol Res
Pract. 207:747–753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ishikawa S, Takenaka K, Yanagihara K,
Miyahara R, Kawano Y, Otake Y, Hasegawa S, Wada H and Tanaka F:
Matrix metalloproteinase-2 status in stromal fibroblasts, not in
tumor cells, is a significant prognostic factor in non-small-cell
lung cancer. Clin Cancer Res. 10:6579–6585. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kitzing TM, Sahadevan AS, Brandt DT,
Knieling H, Hannemann S, Fackler OT, Grosshans J and Grosse R:
Positive feedback between Dia1, LARG and RhoA regulates cell
morphology and invasion. Genes Dev. 21:1478–1483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lizárraga F, Poincloux R, Romao M,
Montagnac G, Le Dez G, Bonne I, Rigaill G, Raposo G and Chavrier P:
Diaphanous-related formins are required for invadopodia formation
and invasion of breast tumor cells. Cancer Res. 69:2792–2800. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanji M, Ishizaki T, Ebrahimi S,
Tsuboguchi Y, Sukezane T, Akagi T, Frame MC, Hashimoto N, Miyamoto
S and Narumiya S: mDia1 targets v-Src to the cell periphery and
facilitates cell transformation, tumorigenesis and invasion. Mol
Cell Biol. 30:4604–4615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clark ES, Whigham AS, Yarbrough WG and
Weaver AM: Cortactin is an essential regulator of matrix
metalloproteinase secretion and extracellular matrix degradation in
invadopodia. Cancer Res. 67:4227–4235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Xu Y, Zhang C, Liu X, Jiang L and
Chen F: Mammalian diaphanous-related formin 1 is required for
motility and invadopodia formation in human U87 glioblastoma cells.
Int J Mol Med. 33:383–391. 2013.PubMed/NCBI
|
|
24
|
Baum O, Hlushchuk R, Forster A, Greiner R,
Clézardin P, Zhao Y, Djonov V and Gruber G: Increased invasive
potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer
cells expressing the beta3 integrin subunit. Int J Oncol.
30:325–332. 2007.PubMed/NCBI
|
|
25
|
Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu
K, Luan J, Duan H, Lu Z, Wang F, et al: Suppression of growth,
migration and invasion of highly-metastatic human breast cancer
cells by berbamine and its molecular mechanisms of action. Mol
Cancer. 8:812009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin CW, Shen SC, Hou WC, Yang LY and Chen
YC: Heme oxygenase-1 inhibits breast cancer invasion via
suppressing the expression of matrix metalloproteinase-9. Mol
Cancer Ther. 7:1195–1206. 2008. View Article : Google Scholar : PubMed/NCBI
|
